基于NanoString技术的弥漫性大B细胞淋巴瘤B细胞相关基因签名分类
研究利用4个队列的微阵列数据(n=970)筛选基因并训练基于NanoString的BAGS2Clinic检测,在88例独立活检样本中验证,与原始BAGS分类器总体符合率为84%(95%CI 72%–93%),亚型特异准确率80%–99%,BAGS分类有望揭示肿瘤生物学及免疫化疗耐药差异。
要点
- BAGS2Clinic检测基于NanoString技术,用于弥漫性大B细胞淋巴瘤的B细胞相关基因签名分类。
- 验证队列88例活检中总体准确率84%(95%CI 72%–93%),亚型特异准确率80%–99%。
- BAGS分类可能为肿瘤生物学及免疫化疗耐药差异提供见解,并辅助预后与治疗指导。
核心结论
- BAGS2Clinic检测与原始BAGS分类器符合良好,有助于将BAGS分类实施为常规临床工具以改善弥漫性大B细胞淋巴瘤患者的预后和治疗指导。
研究设计与样本
- 利用4个不同队列的微阵列数据(n=970)筛选基因并训练基于NanoString的BAGS2Clinic检测。
- 锁定后的检测在88例独立活检样本队列中验证。
主要发现
- BAGS2Clinic检测与原始BAGS分类器总体准确率为84%(95%CI 72%–93%)。
- 亚型特异准确率范围为80%至99%。
临床怎么用
- 作者认为BAGS分类有潜力为肿瘤生物学以及免疫化疗耐药差异提供有价值的见解,从而为弥漫性大B细胞淋巴瘤患者带来新的治疗策略。
- 作者认为BAGS2Clinic可促进BAGS分类作为常规临床工具的实施,以改善弥漫性大B细胞淋巴瘤患者的预后和治疗指导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gene expression profiling (GEP) by microarrays of diffuse large B-cell lymphoma (DLBCL) has enabled the categorization of DLBCL into activated B-cell-like and germinal center B-cell-like subclasses. However, as this does not fully embrace the great diversity of B-cell subtypes, we recently developed a gene expression assay for B-cell-associated gene signature (BAGS) classification. To facilitate quick and easy-to-use BAGS profiling, we developed in this study the NanoString-based BAGS2Clinic assay. Microarray data from 4 different cohorts (n = 970) were used to select genes and train the assay. The locked assay was validated in an independent cohort of 88 sample biopsies. The assay showed good correspondence with the original BAGS classifier, with an overall accuracy of 84% (95% confidence interval, 72% to 93%) and a subtype-specific accuracy ranging between 80% and 99%. BAGS classification has the potential to provide valuable insight into tumor biology as well as differences in resistance to immuno- and chemotherapy that can lead to novel treatment strategies for DLBCL patients. BAGS2Clinic can facilitate this and the implementation of BAGS classification as a routine clinical tool to improve prognosis and treatment guidance for DLBCL patients.
引用
- Michaelsen TY, Richter J, Brøndum RF, et al. A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology. Blood Adv. 2018. PMID: 29967255. doi:10.1182/bloodadvances.2018017988
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。